Abstract
ISG12a is one of the most highly induced genes following treatment of cells with type I interferons (IFNs). The encoded protein belongs to a family of poorly characterized, low molecular weight IFN-inducible proteins that includes 6–16 (G1P3), 1–8U (IFITM3), and 1–8D (IFITM2). Our studies demonstrate that the ISG12a protein associates with or inserts into the mitochondrial membrane. Transient expression of ISG12a led to decreased viable cell numbers and enhanced sensitivity to DNA-damage induced apoptosis, effects that were blocked by Bcl-2 co-expression or treatment with a pan-caspase inhibitor. ISG12a enhanced etoposide induced cytochrome c release, Bax activation and loss of mitochondrial membrane potential. siRNA-mediated inhibition of ectopic ISG12a protein expression prevented the sensitization to etoposide-induced apoptosis and also decreased the ability of IFN-β pretreatment to sensitize cells to etoposide, thereby demonstrating a role for ISG12a in this process. These data suggest that ISG12a contributes to IFN-dependent perturbation of normal mitochondrial function, thus adding ISG12a to a growing list of IFN-induced proteins that impact cellular apoptosis.
Similar content being viewed by others
Abbreviations
- IFITM:
-
IFN inducible transmembrane protein
- IFN:
-
Interferon
- ISG:
-
IFN-stimulated gene
- Mtch:
-
Mitochondrial carrier homolog
- PVDF:
-
Polyvinylidene difluoride
- SP:
-
Signal peptide
- TRAIL:
-
Tumor necrosis factor related apoptosis inducing ligand
- aa:
-
Amino acid
- COX IV:
-
Cytochrome oxidase subunit IV
References
Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD (1998) How cells respond to interferons. Ann Rev Biochem 67:227–264
Deonarain R, Alcami A, Alexious M, Dallman MJ, Gewert DR, Porter AC (2000) Impaired antiviral response and alpha/beta interferon induction in mice lacking beta interferon. J Virol 74:3404–3409
Deonarain R, Cerullo D, Fuse K, Liu PP, Fish EN (2004) Protective role for interferon-beta in coxsackievirus B3 infection. Circulation 110:3540–3543
Leaman DW, Rosebeck S, Borden EC (2005) Biological and clinical properties of type I interferons. In: Disis ML (ed) Immunotherapy of Cancer. Humana Press, pp 365–396
Kokoglu OF, Ucmak H, Hosoglu S, et al (2006) Efficacy and tolerability of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C. J Gastroenterol Hepatol 21:575–580
Lanzillo R, Prinster A, Scarano V, et al (2006) Neuropsychological assessment, quantitative MRI and ApoE gene polymorphisms in a series of MS patients treated with IFN beta-1b. J Neurol Sci 245:141–145
Hwu WJ, Panageas KS, Menell JH, et al (2006) Phase II study of temozolomide plus pegylated interferon-alpha-2b for metastatic melanoma. Cancer 106:2445–2451
Son MJ, Song HS, Kim MH, et al (2006) Synergistic effect and condition of pegylated interferon alpha with paclitaxel on glioblastoma. Int J Oncol 28:1385–1392
Balachandran S, Kim CN, Yeh WC, Mak TW, Bhala KN, Barber GN (1998) Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling. EMBO J 17:6888–6902
Balachandran S, Roberts PC, Kipperman T, et al (2000) Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/Caspase-8 death signaling pathway. J Virol 74:1513–1523
Chawla-Sarkar M, Leaman DW, Borden EC (2001) Preferential induction of apoptosis by interferon (IFN)-beta compared with IFN-alpha2: correlation with TRAIL/Apo2L induction in melanoma cell lines. Clin Cancer Res 7:1821–1831
Chen Q, Gong B, Mahmoud-Ahmed AS, et al (2001) Apo2L/TRAIL and Bcl-2-related proteins regulate type I interferon-induced apoptosis in multiple myeloma. Blood 98:2183–2192
Tanaka N, Sato M, Lamphier MS, et al (1998) Type I interferons are essential mediators of apoptotic death in virally infected cells. Genes Cells 3:29–37
Panaretakis T, Pokrovskaja K, Shoshan MC, Grandér D (2003) Interferon-α-induced apoptosis in U266 cells is associated with activation of the proapoptotic Bcl-2 family members Bak and Bax. Oncogene 22:4543–4556
Yanase N, Ohshima K, Ikegami H, Mizuguchi J (2000) Cytochrome c release, mitochondrial membrane depolarization, caspase-3 activation, and Bax-alpha cleavage during IFN-alpha-induced apoptosis in Daudi B lymphoma cells. J Interferon Cytokine Res 20:1121–1129
Borden EC (1998) Gene regulation and clinical roles for interferons in neoplastic diseases. Oncologist 3:198–203
Chawla-Sarkar M, Leaman DW, Jacobs BS, Borden EC (2001) IFN-beta pretreatment sensitizes human melanoma cells to TRAIL/Apo2 ligand-induced apoptosis. J Immunol 169:847–855
Thyrell L, Erickson S, Zhivotovsky B, et al (2002) Mechanisms of interferon-alpha induced apoptosis in malignant cells. Oncogene 21:1251–1262
Martensen PM, Justesen J (2004) Small ISGs coming forward. J Interferon Cytokine Res 24:1–19
Rasmussen UB, Wolf C, Mattei M, et al (1993) Identification of a new interferon-α-inducible gene (p27) on human chromosome 14q32 and its expression in breast carcinoma. Cancer Res 53:4096–4101
Friedman RL, Manly SP, McMahon M, Kerr IM, Stark GR (1984) Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells. Cell 38:745–755
Kelly JM, Porter ACG, Chernajovsky Y, Gilbert CS, Stark GR, Kerr IM (1986) Characterization of a human gene inducible by α- and β-interferons and its expression in mouse cells. EMBO J 5:1601–1606
Gjermandsen IM, Justesen J, Martensen PM (2000) The interferon-induced gene ISG12a is regulated by various cytokines as the gene 6–16 in human cell lines. Cytokine 12:233–238
Parker N, Porter AC (2004) Identification of a novel gene family that includes the interferon-inducible human genes 6–16 and ISG12. BMC Genomics 5:8
Bani MR, Nicoletti MI, Alkharouf NW, et al (2004) Gene expression correlating with response to paclitaxel in ovarian carcinoma xenografts. Mol Cancer Ther 3:111–121
Han S, Kim S, Heasley LE (2002) Differential gene regulation by specific gain-of-function JNK1 proteins expressed in Swiss 3T3 fibroblasts. J Biol Chem 277:47167–47174
Fjaerli HO, Bukholm G, Krog A, Skjaeret C, Holden M, Nakstad B (2006) Whole blood gene expression in infants with respiratory syncytial virus bronchiolitis. BMC Infect Dis 6:175
Budhu A, Chen Y, Kim J, et al (2007) Induction of a unique gene expression profile in primary human hepatocytes by hepatitis C virus core, NS3 and NS5A proteins. Carcinogenesis (in press)
Labrada L, Liang XH, Zheng W, Johnston C, Levine B (2002) Age-dependent resistance to lethal alphavirus encephalitis in mice: analysis of gene expression in central nervous system and identification of a novel interferon-inducible protective gene, mouse ISG12a. J Virol 76:11688–11703
Levine B, Goldman JE, Jiang HH, Griffin DE, Hardwick JM (1996) Bcl-2 protects mice against fatal alphavirus encephalitis. Proc Natl Acad Sci USA 93:4810–4815
Lewis J, Oyler GA, Ueno K, et al (1999) Inhibition of virus-induced neuronal apoptosis by Bax. Nat Med 5:832–835
Muller M, Briscoe J, Laxton C, et al (1993) The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and -gamma signal transduction. Nature 366:129–135
Kohlhuber F, Rogers NC, Watling D, et al (1997) A JAK1/JAK2 chimera can sustain alpha and gamma interferon responses. Mol Cell Biol 17:695–706
Leaman DW, Chawla-Sarkar M, Jacobs B, et al (2003) Novel Growth and Death Related Interferon Stimulated Genes (ISGs) in Melanoma: Greater Potency of IFN-beta compared with IFN-alpha. J Interferon Cytokine Res 23:745–756
Larner AC, Jonak G, Cheng YS, Korant B, Knight E, Darnell JE Jr (1984) Transcriptional induction of two genes in human cells by beta interferon. Proc Natl Acad Sci USA 81:6733–6737
Haga N, Fujita N, Tsuruo T (2003) Mitochondrial aggregation precedes cytochrome c release from mitochondria during apoptosis. Oncogene 22:5579–5585
Sledz CA, Holko M, de Veer MJ, Silverman RH, Williams BR (2003) Activation of the interferon system by short-interfering RNAs. Nat Cell Biol 5:834–839
Chawla-Sarkar M, Lindner DJ, Liu YF, et al (2003) Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 8:237–249
Lengyel P, Choubey D, Li S, Datta B (1995) The interferon-activatable gene 200 cluster: from structure toward function. Semin Virol 6:202–213
Wu WS, Xu ZX, Hittelman WN, Salomoni P, Pandolfi PP, Chang KS (2003) Promyelocytic leukemia protein sensitizes tumor necrosis factor alpha-induced apoptosis by inhibiting the NF-kappaB survival pathway. J Biol Chem 278:12294–12304
Sun Y, Leaman DW (2005) Involvement of Noxa in cellular apoptotic responses to interferon, double-stranded RNA and virus infection. J Biol Chem 280:15561–15568
Leaman DW, Chawla-Sarkar M, Vyas K, et al (2002) Identification of X-linked Inhibitor of Apoptosis-Associated Factor-1 (XAF1) as an Interferon-stimulated gene that augments TRAIL/Apo2L-induced apoptosis. J Biol Chem 277:28504–28511
Martensen PM, Søgaard TMM, Gjermandsen IM, et al (2001) The interferon alpha induced protein ISG12 is localized to the nuclear membrane. Eur J Biochem 268:5947–5954
Grinberg M, Schwarz M, Zaltsman Y, et al (2005) Mitochondrial carrier homolog 2 is a target of tBid in cells signaled to die by tumor necrosis factor alpha. Mol Cell Biol 25:4579–4590
Schwarz M, Andrade-Navarro MA, Gross A (2007) Mitochondrial carriers and pores: Key regulators of the mitochondrial apoptotic program? Apoptosis 12:869–876
Xu X, Shi YX, Gao W, et al (2002) The novel presenilin-1-associated protein is a proapoptotic mitochondrial protein. J Biol Chem 277:48913–48922
Leibowitz-Amit R, Tsarfaty G, Abargil Y, Yerushalmi GM, Horev J, Tsarfaty I (2006) Mimp, a mitochondrial carrier homologue, inhibits Met-HGF/SF-induced scattering and tumorigenicity by altering Met-HGF/SF signaling pathways. Cancer Res 66:8687–8697
Nguyen DM, Yeow WS, Ziauddin MF, et al (2006) The essential role of the mitochondria-dependent death-signaling cascade in chemotherapy-induced potentiation of Apo2L/TRAIL cytotoxicity in cultured thoracic cancer cells: amplified caspase 8 is indispensable for combination-mediated massive cell death. Cancer J 12:257–273
Samraj AK, Sohn D, Schulze-Osthoff K, Schmitz I (2007) Loss of caspase-9 reveals its essential role for caspase-2 activation and mitochondrial membrane depolarization. Mol Biol Cell 18:84–93
Liang XH, Kleeman LK, Jiang HH, et al (1998) Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein. J Virol 72:8586–8596
Matarrese P, Di Biase L, Santodonato L, et al (2002) Type I interferon gene transfer sensitizes melanoma cells to apoptosis via a target activity on mitochondrial function. Am J Pathol 160:1507–1520
Tahara E Jr, Tahara H, Kanno M, et al (2005) G1P3, an interferon inducible gene 6–16, is expressed in gastric cancers and inhibits mitochondrial-mediated apoptosis in gastric cancer cell line TMK-1 cell. Cancer Immunol Immunother 54:729–740
Cheriyath V, Glaser KB, Waring JF, et al (2007) G1P3, an IFN-induced survival factor, antagonizes TRAIL-induced apoptosis in human myeloma cells. J Clin Invest 117:3107–3117
Acknowledgements
We wish to thank Han-Fei Ding for the Bcl-2 and Bax expression plasmids. The authors have no commercial affiliations or conflicts of interest to declare. Supported by grants 9R01 AI068133-07 from the NIH, American Heart Association Ohio Valley Grant 0655387B, and a University of Toledo deArce Fellowship (to D.W.L.).
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Rosebeck, S., Leaman, D.W. Mitochondrial localization and pro-apoptotic effects of the interferon-inducible protein ISG12a. Apoptosis 13, 562–572 (2008). https://doi.org/10.1007/s10495-008-0190-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10495-008-0190-0